The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
